blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2903450

EP2903450 - USE OF AN ION EXCHANGE MEMBRANE TO REMOVE IMPURITIES FROM CELL-BINDING AGENT CYTOTOXIC AGENT CONJUGATES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.04.2017
Database last updated on 14.11.2024
FormerRequest for examination was made
Status updated on  19.12.2016
Most recent event   Tooltip07.04.2017Application deemed to be withdrawnpublished on 10.05.2017  [2017/19]
Applicant(s)For all designated states
ImmunoGen, Inc.
830 Winter Street
Waltham, MA 02451-1477 / US
[2015/33]
Inventor(s)01 / LI, Xinfang
85 Brookline Street
Newton, Massachusetts 02467 / US
02 / CHENG, Wenjie
1 Cherry Street
Lexington, Massachusetts 02421 / US
 [2015/33]
Representative(s)Evenson, Jane Harriet, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
[2015/33]
Application number, filing date13843881.704.10.2013
[2015/33]
WO2013US63503
Priority number, dateUS201261709871P04.10.2012         Original published format: US 201261709871 P
[2015/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014055893
Date:10.04.2014
Language:EN
[2014/15]
Type: A1 Application with search report 
No.:EP2903450
Date:12.08.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 10.04.2014 takes the place of the publication of the European patent application.
[2015/33]
Search report(s)International search report - published on:US10.04.2014
(Supplementary) European search report - dispatched on:EP11.04.2016
ClassificationIPC:A23J1/10, A61K47/48, C07K16/46
[2015/33]
CPC:
C07K16/065 (EP,US); A61K47/6801 (EP,US); A61K47/6849 (EP,US);
C07K16/2863 (US); C07K16/2878 (US); C07K16/2896 (US);
C07K16/32 (EP,US); C07K16/40 (US); C07K2317/24 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/33]
TitleGerman:VERWENDUNG EINER IONENAUSTAUSCHMEMBRAN ZUM ENTFERNEN VON VERUNREINIGUNGEN AUS KONJUGATEN AUS ZELL-BINDENDEM MITTEL UND ZYTOTOXISCHEM MITTEL[2015/33]
English:USE OF AN ION EXCHANGE MEMBRANE TO REMOVE IMPURITIES FROM CELL-BINDING AGENT CYTOTOXIC AGENT CONJUGATES[2015/33]
French:UTILISATION D'UNE MEMBRANE ÉCHANGEUSE D'IONS POUR ÉLIMINER DES IMPURETÉS DE CONJUGUÉS AGENT DE FIXATION AUX CELLULES-AGENT CYTOTOXIQUE[2015/33]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase15.04.2015National basic fee paid 
15.04.2015Search fee paid 
15.04.2015Designation fee(s) paid 
15.04.2015Examination fee paid 
Examination procedure15.04.2015Examination requested  [2015/33]
20.11.2015Amendment by applicant (claims and/or description)
10.11.2016Application deemed to be withdrawn, date of legal effect  [2017/19]
20.12.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/19]
Fees paidRenewal fee
27.10.2015Renewal fee patent year 03
27.10.2016Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2007024536  (IMMUNOGEN INC [US], et al) [Y] 1-15 * paragraphs [0008] , [0009] , [0015] *;
 [Y]US2011166319  (DAI YONG [US], et al) [Y] 1-15 * paragraph [0010] * * paragraph [0020] *;
 [YP]US2012253021  (LI XINFANG [US], et al) [YP] 1-15* claim 1 *;
 [Y]  - MCDONAGH CHARLOTTE F ET AL, "Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index", MOLECULAR CANCER THERAPEUTICS, AMERICAN ASSOCIATION OF CANCER RESEARCH, US, vol. 7, no. 9, doi:10.1158/1535-7163.MCT-08-0295, ISSN 1535-7163, (20080901), pages 2913 - 2923, (20080911), XP009151912 [Y] 1-15 * page 2914, column 2, paragraph 2 * * abstract *

DOI:   http://dx.doi.org/10.1158/1535-7163.MCT-08-0295
 [Y]  - VAN REIS R ET AL, "High-performance tangential flow filtration using charged membranes", JOURNAL OF MEMBRANE SCIENCE, ELSEVIER BV, NL, (19990701), vol. 159, no. 1-2, doi:10.1016/S0376-7388(99)00048-4, ISSN 0376-7388, pages 133 - 142, XP004169169 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/S0376-7388(99)00048-4
International search[X]US2011206658  (CROWLEY CRAIG [US], et al);
 [Y]EP2468304  (IMMUNOGEN INC [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.